Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations. We help you understand fair value estimates and potential upside or downside scenarios for any stock.
Heartbeam (BEAT) has recently traded near $0.91, reflecting a modest intraday gain of approximately 2.8% as of mid-May 2026. The stock continues to oscillate within a tight range, with support established around $0.86 and resistance near $0.96. Trading volumes have been relatively subdued in recent
Heartbeam (BEAT) Gains +2.80% — Support Holds at $0.86 2026-05-13 - Company Analysis
BEAT - Stock Analysis
4578 Comments
857 Likes
1
Gwain
Engaged Reader
2 hours ago
If only I had read this before.
👍 233
Reply
2
Pear
Community Member
5 hours ago
If only I had checked this sooner.
👍 223
Reply
3
Mylez
Insight Reader
1 day ago
I should’ve taken more time to think.
👍 254
Reply
4
Dailey
Returning User
1 day ago
I need to hear from others on this.
👍 144
Reply
5
Geddy
Registered User
2 days ago
US stock product cycle analysis and innovation pipeline tracking to understand future growth drivers and upcoming catalysts for stock appreciation. Our product research helps you identify companies with upcoming catalysts that could drive significant stock price appreciation in the future. We provide product pipeline analysis, innovation scoring, and catalyst tracking for comprehensive coverage. Find future winners with our comprehensive product cycle analysis and innovation tracking tools for growth investing.
👍 202
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.